Outset Medical has raised $76.5 million in a Series C round for its Tablo Hemodialysis System. The all-in-one dialysis device is meant to help patients access lower cost and labor intensive dialysis care. The device eliminates the need for centralized water processing equipment, making Tablo suitable for multiple care settings and cutting the cost of dialysis care. The company is hoping to extend Tablo Hemodialysis System’s scope to home use in the future. Read the full press release here.